Anaïs Potron

Journal articles

2023

ref_biblio

Damien Fournier, Pauline Triponney, Loreen Gabriel, Patrick Plésiat, Katy Jeannot, et al.. Evaluation of 5 rapid colorimetric and immunochromatographic tests for the detection of carbapenemases in Pseudomonas aeruginosa and Acinetobacter spp. isolates. European Journal of Clinical Microbiology and Infectious Diseases, 2023, 42 (8), pp.1043-1045. ⟨10.1007/s10096-023-04631-8⟩. ⟨hal-04225777⟩

Accès au bibtex

ref_biblio

Susie Gaillot, Saoussen Oueslati, Jean-Baptiste Vuillemenot, Maxime Bour, Bogdan Iorga, et al.. Genomic characterization of an NDM-9-producing $Acinetobacter\ baumannii$ clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9. Frontiers in Microbiology, 2023, 14, pp.1253160. ⟨10.3389/fmicb.2023.1253160⟩. ⟨hal-04204833⟩

Accès au texte intégral et bibtex

ref_biblio

Katy Jeannot, Susie Gaillot, Pauline Triponney, Sylvain Portets, Valentin Pourchet, et al.. Performance of the Disc Diffusion Method, MTS Gradient Tests and Two Commercially Available Microdilution Tests for the Determination of Cefiderocol Susceptibility in Acinetobacter spp.. Microorganisms, 2023, 11 (8), pp.1971. ⟨10.3390/microorganisms11081971⟩. ⟨hal-04225792⟩

Accès au bibtex

ref_biblio

Agnese Lupo, Benoît Valot, Estelle Saras, Antoine Drapeau, Marine Robert, et al.. Multiple host colonization and differential expansion of multidrug-resistant ST25-Acinetobacter baumannii clades. Scientific Reports, 2023, 13 (1), pp.21854. ⟨10.1038/s41598-023-49268-x⟩. ⟨anses-04375645⟩

Accès au texte intégral et bibtex

2022

ref_biblio

Kévin Bouiller, Souheil Zayet, Paul-Emile Lalloz, Anaïs Potron, Vincent Gendrin, et al.. Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales. Antibiotics, 2022, 11 (2), pp.198. ⟨10.3390/antibiotics11020198⟩. ⟨hal-04225981⟩

Accès au texte intégral et bibtex

ref_biblio

Anne-Sophie Godeux, Elin Svedholm, Samuel Barreto, Anaïs Potron, Samuel Venner, et al.. Erratum for Godeux et al., “Interbacterial Transfer of Carbapenem Resistance and Large Antibiotic Resistance Islands by Natural Transformation in Pathogenic Acinetobacter”. mBio, 2022, 13 (2), pp.e0052622. ⟨10.1128/mbio.00526-22⟩. ⟨hal-04225950⟩

Accès au texte intégral et bibtex

ref_biblio

Anne-Sophie Godeux, Elin Svedholm, Samuel Barreto, Anaïs Potron, Samuel Venner, et al.. Interbacterial Transfer of Carbapenem Resistance and Large Antibiotic Resistance Islands by Natural Transformation in Pathogenic Acinetobacter. mBio, 2022, 13 (1), pp.e02631-21. ⟨10.1128/mbio.02631-21⟩. ⟨hal-03719631⟩

Accès au texte intégral et bibtex

ref_biblio

Amélie Lombes, Rémy Bonnin, Frédéric Laurent, Hélène Guet-Revillet, Emmanuelle Bille, et al.. High Prevalence of OXA-23 Carbapenemase-Producing Proteus mirabilis among Amoxicillin-Clavulanate-Resistant Isolates in France. Antimicrobial Agents and Chemotherapy, 2022, 66 (2), pp.e0198321. ⟨10.1128/AAC.01983-21⟩. ⟨hal-04225971⟩

Accès au bibtex

ref_biblio

Amélie Lombes, Rémy A. Bonnin, Frédéric Laurent, Hélène Guet-Revillet, Emmanuelle Bille, et al.. High prevalence of OXA-23 carbapenemase-producing Proteus mirabilis among amoxicillin-clavulanate resistant isolates in France. Antimicrobial Agents and Chemotherapy, 2022, 66 (2), pp.e0198321. ⟨10.1128/AAC.01983-21⟩. ⟨hal-03505721⟩

Accès au texte intégral et bibtex

ref_biblio

Benoît Pilmis, Gauthier Péan de Ponfilly, Eric Farfour, Anne-Gaëlle Ranc, Vincent Fihman, et al.. Epidemiology and clinical characteristics of Klebsiella spp. meningitis in France. Infectious Diseases Now, 2022, 52 (2), pp.82-86. ⟨10.1016/j.idnow.2021.05.006⟩. ⟨hal-04144819⟩

Accès au bibtex

ref_biblio

Brandon Robin, Marion Nicol, Hung Le, Ali Tahrioui, Annick Schaumann, et al.. MacAB-TolC, a new determinant of biofilm in Acinetobacter baumannii. Frontiers in Microbiology, 2022, 12, pp.785161. ⟨10.3389/fmicb.2021.785161⟩. ⟨hal-03854930⟩

Accès au texte intégral et bibtex

ref_biblio

Jean-Baptiste Vuillemenot, Maxime Bour, Racha Beyrouthy, Richard Bonnet, Maria-Halima Laaberki, et al.. Genomic analysis of CTX-M-115 and OXA-23/-72 co-producing Acinetobacter baumannii , and their potential to spread resistance genes by natural transformation. Journal of Antimicrobial Chemotherapy, 2022, 77 (6), pp.1542-1552. ⟨10.1093/jac/dkac099⟩. ⟨hal-03870143⟩

Accès au bibtex

2021

ref_biblio

Charles Lefèvre, Romain Pelletier, Alban Le Monnier, Stéphane Corvec, Emmanuelle Bille, et al.. Clinical relevance and antimicrobial susceptibility profile of the unknown human pathogen Corynebacterium aurimucosum. Journal of Medical Microbiology, 2021, 70 (3), pp.001334. ⟨10.1099/jmm.0.001334⟩. ⟨hal-04096890⟩

Accès au bibtex

ref_biblio

Guillaume Miltgen, Maxime Bour, Jérôme Allyn, Nicolas Allou, Thibaut Vedani, et al.. Molecular and epidemiological investigation of a colistin-resistant OXA-23-/NDM-1-producing Acinetobacter baumannii outbreak in the Southwest Indian Ocean Area. International Journal of Antimicrobial Agents, 2021, 58 (4), pp.106402. ⟨10.1016/j.ijantimicag.2021.106402⟩. ⟨hal-04226073⟩

Accès au texte intégral et bibtex

ref_biblio

A. Zeggay, R. Anxionnat, C. Chirouze, P. Plésiat, K. Jeannot, et al.. An unusual digestive infection due to Francisella tularensis: A case report. Infectious Diseases Now, 2021, ⟨10.1016/j.idnow.2021.02.001⟩. ⟨hal-03369690⟩

Accès au bibtex

2020

ref_biblio

E. Farfour, N. Degand, E. Riverain, V. Fihman, C. Le Brun, et al.. Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints. Médecine et Maladies Infectieuses, 2020, 50 (7), pp.611-616. ⟨10.1016/j.medmal.2020.07.003⟩. ⟨hal-04298521⟩

Accès au bibtex

ref_biblio

E. Farfour, N. Degand, E. Riverain, V. Fihman, C. Le Brun, et al.. Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints. Médecine et Maladies Infectieuses, 2020, 50 (7), pp 611-616. ⟨10.1016/j.medmal.2020.07.003⟩. ⟨hal-03471671⟩

Accès au bibtex

ref_biblio

E. Farfour, N. Degand, E. Riverain, V. Fihman, C. Le Brun, et al.. Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints. Médecine et Maladies Infectieuses, 2020, 50 (7), pp.611-616. ⟨10.1016/j.medmal.2020.07.003⟩. ⟨hal-04226097⟩

Accès au bibtex

ref_biblio

Felix Lötsch, Barbara Albiger, Dominique Monnet, Marc Struelens, Harald Seifert, et al.. Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019. Eurosurveillance, 2020, 25 (45), ⟨10.2807/1560-7917.ES.2020.25.45.2001735⟩. ⟨hal-03520455⟩

Accès au bibtex

ref_biblio

G. Royer, F. Fourreau, B. Boulanger, M. Mercier-Darty, D. Ducellier, et al.. Local outbreak of extended-spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone. Journal of Hospital Infection, 2020, 104 (1), pp.33-39. ⟨10.1016/j.jhin.2019.07.014⟩. ⟨hal-04283219⟩

Accès au bibtex

ref_biblio

Guilhem Royer, Frédéric Fourreau, Boris Boulanger, Mélanie Mercier-Darty, David Ducellier, et al.. Local outbreak of extended-spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone. Journal of Hospital Infection, 2020, 104 (1), pp.33-39. ⟨10.1016/j.jhin.2019.07.014⟩. ⟨hal-04226142⟩

Accès au texte intégral et bibtex

2019

ref_biblio

Anaïs Potron, Damien Fournier, Cécile Emeraud, Pauline Triponney, Patrick Plésiat, et al.. Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters. Antimicrobial Agents and Chemotherapy, 2019, 63 (9), ⟨10.1128/AAC.00968-19⟩. ⟨hal-04226190⟩

Accès au bibtex

ref_biblio

Anaïs Potron, Didier Hocquet, Pauline Triponney, Patrick Plesiat, Xavier Bertrand, et al.. Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community. Antimicrobial Agents and Chemotherapy, 2019, 63 (6), ⟨10.1128/AAC.00191-19⟩. ⟨hal-02315697⟩

Accès au bibtex

ref_biblio

Anaïs Potron, Jean-Baptiste Vuillemenot, Hélène Puja, Pauline Triponney, Maxime Bour, et al.. ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin. Journal of Antimicrobial Chemotherapy, 2019, 74 (9), pp.2544-2550. ⟨10.1093/jac/dkz241⟩. ⟨hal-04226270⟩

Accès au bibtex

ref_biblio

Anaïs Potron, Maxime Bour, Pauline Triponney, Joris Muller, Christelle Koebel, et al.. Sequential emergence of colistin and rifampicin resistance in an OXA-72- producing outbreak strain of Acinetobacter baumannii. International Journal of Antimicrobial Agents, 2019, 53 (5), pp.669-673. ⟨10.1016/j.ijantimicag.2019.01.012⟩. ⟨hal-04226586⟩

Accès au bibtex

ref_biblio

Anaïs Potron, Didier Hocquet, Pauline Triponney, Patrick Plésiat, Xavier Bertrand, et al.. Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community. Antimicrobial Agents and Chemotherapy, 2019, 63 (6), ⟨10.1128/AAC.00191-19⟩. ⟨hal-04226443⟩

Accès au bibtex

ref_biblio

Anaïs Potron, Damien Fournier, Cécile Emeraud, Pauline Triponney, Patrick Plésiat, et al.. Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters. Antimicrobial Agents and Chemotherapy, 2019, 63 (9), ⟨10.1128/AAC.00968-19⟩. ⟨hal-04225916⟩

Accès au bibtex

ref_biblio

Pauline Triponney, Anaïs Potron, Thierry Naas, Laurent Dortet, Damien Fournier, et al.. Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters. Antimicrobial Agents and Chemotherapy, 2019, 63 (9), pp.1469-1472. ⟨10.1128/AAC.00968-19⟩. ⟨hal-03505678⟩

Accès au bibtex

2018

ref_biblio

Laurent Dortet, Anaïs Potron, Rémy A. Bonnin, Patrick Plésiat, Thierry Naas, et al.. Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria. Scientific Reports, 2018, 8 (1), pp.669-673. ⟨10.1038/s41598-018-35041-y⟩. ⟨hal-03505776⟩

Accès au texte intégral et bibtex

ref_biblio

Laurent Dortet, Rémy Bonnin, Ivana Pennisi, Laura Gauthier, Agnès Jousset, et al.. Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. Journal of Antimicrobial Chemotherapy, 2018, 73 (12), pp.3359-3367. ⟨10.1093/jac/dky330⟩. ⟨hal-02064649⟩

Accès au bibtex

ref_biblio

Agnès Jousset, Laura Dabos, Rémy Bonnin, Delphine Girlich, Anaïs Potron, et al.. CTX-M-15-Producing Shewanella sp Clinical Isolate Expressing OXA-535, a Chromosome-Encoded OXA-48 Variant, Putative Progenitor of the Plasmid-Encoded OXA-436. Antimicrobial Agents and Chemotherapy, 2018, 62 (1), pp.e01879-17. ⟨10.1128/AAC.01879-17⟩. ⟨hal-01690618⟩

Accès au texte intégral et bibtex

2017

ref_biblio

Aurélien Dinh, Benjamin Davido, Ruxandra Calin, Julie Paquereau, Clara Duran, et al.. Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladder. Spinal Cord Series and Cases, 2017, 3, pp.17019. ⟨10.1038/scsandc.2017.19⟩. ⟨hal-01685434⟩

Accès au bibtex

ref_biblio

Anaïs Potron, Sandrine Bernabeu, Gaelle Cuzon, Valérie Pontiès, Hervé Blanchard, et al.. Analysis of OXA-204 carbapenemase-producing Enterobacteriaceae reveals possible endoscopy-associated transmission, France, 2012 to 2014. Eurosurveillance, 2017, 22 (49), ⟨10.2807/1560-7917.ES.2017.22.49.17-00048⟩. ⟨hal-01690478⟩

Accès au texte intégral et bibtex

ref_biblio

Anaïs Vallet, Nicolas Noel, Rachid Bahi, Elina Teicher, Yann Quertainmont, et al.. Recurrent obstructive acute pyelonephritis: A rare form of Actinotignum (Actinobaculum) schaalii infection in a HIV-1 infected patient. Anaerobe, 2017, 43, pp.75 - 77. ⟨10.1016/j.anaerobe.2016.12.004⟩. ⟨hal-01690659⟩

Accès au bibtex

2016

ref_biblio

Laurent Dortet, Anais Potron, Patrice Nordmann, Laurent Poirel. Characterisation of OXA-244, a chromosomally-encoded OXA-48-like β-lactamase from Escherichia coli. International Journal of Antimicrobial Agents, 2016, 47 (1), pp.102-103. ⟨10.1016/j.ijantimicag.2015.10.015⟩. ⟨hal-03505782⟩

Accès au bibtex

2015

ref_biblio

Anaïs Potron, Laurent Poirel, Patrice Nordmann. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology. International Journal of Antimicrobial Agents, 2015, 45 (6), pp.568-585. ⟨10.1016/j.ijantimicag.2015.03.001⟩. ⟨hal-03505785⟩

Accès au bibtex

2013

ref_biblio

Anaïs Potron, Emilie Rondinaud, Laurent Poirel, Olivier Belmonte, Sophie Boyer, et al.. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae. International Journal of Antimicrobial Agents, 2013, 41 (4), pp.325-329. ⟨10.1016/j.ijantimicag.2012.11.007⟩. ⟨hal-03505792⟩

Accès au bibtex

ref_biblio

Anaïs Potron, Laurent Poirel, Patrice Nordmann. Derepressed Transfer Properties Leading to the Efficient Spread of the Plasmid Encoding Carbapenemase OXA-48. Antimicrobial Agents and Chemotherapy, 2013, 58 (1), pp.467-471. ⟨10.1128/AAC.01344-13⟩. ⟨hal-03505788⟩

Accès au bibtex

2012

ref_biblio

Anaïs Potron, Patrice Nordmann, Laurent Poirel. Characterization of OXA-204, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 2012, 57 (1), pp.633-636. ⟨10.1128/AAC.01034-12⟩. ⟨hal-03505794⟩

Accès au bibtex

Conference papers

2020

ref_biblio

Brandon Robin, Sébastien Massier, Anaïs Potron, Jean-Baptiste Vuillemenot, T. Jouenne, et al.. A SIR2 family protein impacts biofilm formation by post-translational modifications in Acinetobacter baumannii. Biofilm 9_online Conference, Sep 2020, Karlsruhe, Germany. ⟨hal-03054021⟩

Accès au bibtex

Poster communications

2022

ref_biblio

Agnese Lupo, Benoit Valot, Antoine Drapeau, Estelle Saras, Bour Maxime, et al.. Phylogenetic and resistome analysis of epidemic multidrug-resistant Acinetobacter baumannii clone. FEMS Conference on Microbiology, Jun 2022, Belgrade, Serbia. ⟨anses-04542385⟩

Accès au texte intégral et bibtex